Related Experiment Video
Updated: Aug 11, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Coagulant activity of factor VII (FVIIc) in the elderly with ischemic heart disease]
R A Fernández de la Puebla Giménez1, P Ceballos, P Pérez Martínez
1Unidad de Lípidos y Arteriosclerosis. Hospital Universitario Reina Sofía. Córdoba.
Insights
Coagulant activity of factor VII (FVIIc) may be a significant coronary risk factor in elderly individuals over 75. Higher FVIIc levels were observed in older patients with coronary diseases, suggesting a potential link to cardiovascular risk in this population.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Geriatrics
Context:
- Coagulant activity of factor VII (FVIIc) is a known risk factor for cardiovascular disease in middle-aged individuals.
- The role of FVIIc in the elderly population regarding cardiovascular risk remains largely unexplored.
- This study investigates the potential association between FVIIc levels and coronary heart disease in older adults.
Purpose:
- To evaluate whether factor VII coagulant activity (FVIIc) serves as a risk factor for coronary heart disease in individuals aged 65-85.
- To determine if FVIIc levels differ between elderly patients with myocardial infarction/unstable angina and age-matched controls without coronary heart disease.
Summary:
- A case-control study involving 79 patients (65-85 years) with recent myocardial infarction/unstable angina and 81 controls without coronary heart disease was conducted.
- No significant difference in FVIIc was found in the total group, but levels were higher in cases over 75 years old (p < 0.05).
- Multivariable analysis indicated that serum glucose, body mass index, and HDL cholesterol were associated with FVIIc in patients with coronary disease.
Impact:
- Findings suggest that elevated FVIIc may be a significant coronary risk factor specifically in the very elderly (over 75 years).
- This research highlights the importance of considering FVIIc in cardiovascular risk assessment for older adult populations.
- Further investigation into the mechanisms linking FVIIc to cardiovascular disease in the elderly is warranted.
Background:
The coagulant activity of factor VII increases with age and is a risk factor in middle aged subjects. Its role in elderly people is still unknown. The aim of this study was to evaluate whether or not FVIIc is a risk factor in such population.
Study Design:
cases and controls study. The group of cases consisted of 79 subjects fulfilling the following criteria: a) age between 65 and 85 years, and b) admission in the Valle de los Pedroches Hospital of Pozoblanco (Córdoba, Spain) due to a myocardial infarction and/or unstable angina, 2 or 6 months before their enrollment. The control group consisted of 81 subjects of similar age, chosen at random from the municipal registry, and excluding those with coronary heart disease. Factor VIIc was measured by conventional methods. Plasma samples were diluted with deficient plasma in FVIIc, and coagulation times were measured after adding thromboplastin and calcium. The measures were compared with a <
Results:
There were no significant differences in the FVIIc between cases (118.3 [SD 22.2]) and controls (116.5 [24.4]; p = 0.630) in the total group. When classified according to their age, it was observed that within the group of more than 75 years old, cases had a higher FVIIc than controls (124.1 [18.2] vs 113.3 [23.5]; p < 0. 05). When the classification was carried out according to sex, male presented similar results than the total group. Bivariable analysis showed, in subjects with coronary diseases, that FVIIc was related to total cholesterol, cLDL, apoprotein B, body mass index, HbA1c, and age. Factors related to FVIIc in the multivariable analysis were basal glucose serum level, body mass index; cHDL was negatively related.
Conclusions:
FVIIc is higher in very old subjects with coronary diseases so it may be a significant coronary risk factor in this age group.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease III: Clinical Manifestations
Venous Thrombosis III: Interprofessional Care

